From: Periostin is up-regulated in high grade and high stage prostate cancer
Characteristic | No. of cases | No. of events | 3-year PSA relapse rate (± SE) in % | p-values |
---|---|---|---|---|
Periostin stromal | Â | Â | Â | 0.373 |
low | 152 | 46 | 77.1 ± 3.5 |  |
high | 59 | 22 | 72.7 ± 5.8 |  |
Periostin epithelial | Â | Â | Â | 0.722 |
low | 133 | 41 | 77.7 ± 3.6 |  |
high | 78 | 27 | 72.6 ± 5.1 |  |
Age | Â | Â | Â | 0.514 |
≤ 64 years | 108 | 33 | 79.2 ± 4.0 |  |
>64 years | 103 | 35 | 74.3 ± 4.3 |  |
pT status | Â | Â | Â | < 0.001 |
pT1/2 | 153 | 37 | 84.2 ± 3.0 |  |
pT3/4 | 58 | 31 | 56.4 ± 6.7 |  |
Gleason score | Â | Â | Â | < 0.001 |
3-6 | 46 | 4 | 93.2 ± 3.8 |  |
7 | 131 | 44 | 76.0 ± 3.8 |  |
8-10 | 34 | 20 | 52.0 ± 8.7 |  |
Residual tumour a | Â | Â | Â | < 0.001 |
R0 | 151 | 34 | 83.8 ± 3.0 |  |
R1 | 59 | 33 | 60.4 ± 6.4 |  |